Hypertonic Saline: Clinical Trials

7 trials of Hypertonic Saline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 withdrawn. 7 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 5, Terminated 1, Withdrawn 1
Phase 25Completed 3, Terminated 1, Withdrawn 1

Follow Hypertonic Saline: new trials by email Literature Review of Hypertonic Saline trials Research Report on Hypertonic Saline

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multilevel Models of Therapeutic Response in the Lungs
Hypertonic Saline, Isotonic Saline, Indium-DTPA - Cystic Fibrosis
Phase 1CompletedTim Corcoran562017-01-012023-01-13
IVF in Pediatric Concussion
Hypertonic Saline - Pediatric Mild Traumatic Brain Injury
Phase 1 / Phase 2TerminatedWashington University School of Medicine22015-10-012016-04-28
Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects
Xylitol, Hypertonic saline - Cystic Fibrosis
Phase 1 / Phase 2CompletedJoseph Zabner632013-01-222021-06-25
Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
Xylitol, Hypertonic saline - Cystic Fibrosis
Phase 1 / Phase 2CompletedJoseph Zabner302011-05-012018-10-24
Hypertonic Saline as Therapy for Pediatric Concussion
Hypertonic Saline, Normal Saline - Pain
Phase 1 / Phase 2CompletedUniversity of California, San Diego442010-03-012019-04-16
Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis
Hypertonic Saline - Cystic Fibrosis
Phase 1CompletedThe Hospital for Sick Children132006-03-012025-02-13
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies
Edetate Calcium Disodium, Ethanol, Trimethoprim-sulfamethoxazole - Chronic Myeloproliferative Disorders, Infection
Phase 1 / Phase 2WithdrawnM.D. Anderson Cancer Center2013-02-15

Conditions studied

Cystic Fibrosis (4)  ·  Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Congenital Abnormalities (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Infections (1)  ·  Intraocular Lymphoma (1)  ·  Leukemia (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Mast-Cell (1)

Sponsors

Joseph Zabner (2)  ·  M.D. Anderson Cancer Center (1)  ·  The Hospital for Sick Children (1)  ·  Tim Corcoran (1)  ·  University of California, San Diego (1)  ·  Washington University School of Medicine (1)

Countries

United States (5)  ·  Canada (1)

Top investigators

Angela K Lumba, MD (1)  ·  Felix Ratjen, MD, FRCP(C) (1)  ·  Jan L Launspach, R.N., CCRC (1)  ·  Jorge Cortes, MD (1)  ·  Joseph Zabner, M.D. (1)  ·  Joseph Zabner, MD (1)  ·  Lakshmi Durairaj, M.D. (1)  ·  Lakshmi Durairaj, MD (1)  ·  Mary Hilfiker, MD (1)  ·  Patrick Chaftari, MD (1)  ·  Tim Corcoran, Ph.D. (1)

Results publications

PMID 31327670, PMID 32671834, PMID 34674574

NIH funding

U01HL131046 (1)